The Rosuvastatin Tablets, cataloged under National Stock Number 6505-01-714-4783, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Ascend Laboratories Llc Dba Ascend Laboratories Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-714-4783 |
| Primary Part Number | NDC67877-0442-30 |
| Item Name | Rosuvastatin Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Ascend Laboratories Llc Dba Ascend Laboratories Llc |
| Status | ACTIVE |
| Administration | ORAL |
| Coating Feature | FILM, NONENTERIC |
| Primary Container Content Quantity | 30.0 TABLETS |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC67877-0442-30 PRIMARY | Ascend Laboratories Llc Dba Ascend Laboratories Llc (USA) |
| NDC00310-7590-30 PRIMARY | Astrazeneca Pharmaceuticals Lp (USA) |
| Reference | Meaning |
|---|---|
| CRESTOR | 5/1 Secondary reference Astrazeneca Pharmaceuticals Lp |
| 1656881 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM239300 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-714-4783 is a Rosuvastatin Tablets, manufactured by Ascend Laboratories Llc Dba Ascend Laboratories Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-714-4783 has 2 manufacturer part numbers on file: NDC67877-0442-30 (Ascend Laboratories Llc Dba Ascend Laboratories Llc), NDC00310-7590-30 (Astrazeneca Pharmaceuticals Lp).
Key specifications for NDC67877-0442-30: Administration: ORAL; Coating Feature: FILM, NONENTERIC; Primary Container Content Quantity: 30.0 TABLETS; Primary Container Type: BOTTLE. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.